Skip to main content

J&J Consulting Group- FDA Regulatory Compliance

Current Good Manufacturing Practice for Finished Pharmaceuticals

21 CFR Part 211 Regulatory Strategies for Drugs & Biologics. 

99%

Satisfy client

Hand holding yellow medicine capsules
Gloved medical worker refusing COVID-19 vaccine vials
Years of Experience
0 +

FDA cGMP COMPLIANCE

From quality unit to release

FDA holds drug makers to the strictest cGMP rules of any product category. Every batch must be made under validated processes, tested against approved specifications and released by an independent quality unit. JJCC Group builds and repairs those systems for Rx, OTC, API and biologics manufacturers, and for the brands that hire them.

Our Services

Our 21 CFR cGMP Compliance Services

Our specialized pharmaceutical consulting services provide expert guidance in contract manufacturing oversight, CDMO selection and management, biologics compliance, cGMP training, and FDA-ready quality assurance — helping drug manufacturers achieve regulatory excellence at every stage of product development.

Finished drug cGMP

Finished drug cGMP

21 CFR Parts 210 and 211

01/
Biologics

Biologics

21 CFR Parts 600–680, plus Parts 210 and 211

02/
APIs

APIs

FD&C Act 501(a)(2)(B); ICH Q7 as FDA's recommendation

03/
Electronic records and signatures

Electronic records and signatures

21 CFR Part 11

04/
Registration and listing

Registration and listing

21 CFR Part 207

05/
OTC monographs

OTC monographs

21 CFR Part 1FD&C Act 505G (CARES Act, 2020); OTC monograph orders1

06/

Why choose us?

Why Partner With JJCC Group Consultants
years in regulatory affairs
0 +
Satisfaction Rate
0 %
Medical Partner
0 +

Core Services

Our services include

We offer comprehensive support including cGMP facility setup, SOP development, process validation, audits, training, and regulatory compliance for pharmaceutical and biologic manufacturers.

Quality systems

under Part 211: quality unit, document control, deviations, change control, CAPA.

SOPs

master production records and batch records.

Process validation

across all three stages: design, qualification and continued verification.

Equipment and utility qualification

(IQ/OQ/PQ) and cleaning validation

Laboratory controls

method validation, stability programs, OOS and OOT investigations.

Rapid Response Remedy

for form 483 observations and Warning letter response

Robust CAPA Development

rooted in genuine root cause analysis

Mock FDA inspections

that mirror real agency expectations and methodology against 21 CFR 211 for drug and Biological products

Sustained audit readiness

programs that prepare your team for any regulatory visit

Comprehensive cGMP support for drug and biologics manufacturers

cGMP READINESS

Ready to strengthen your cGMP compliance?

Most drug 483s trace back to a few weak spots: investigations that stop too early, procedures not followed, lab controls and cleaning. We look there first, and we fix the system, not just the finding.

Best Compliance with 5 Star

Smiling male doctor in white coat, arms crossed
Scientist in lab coat holding pipette
Smiling female doctor with stethoscope
Smiling male doctor in white coat, arms crossed

99% Happy Clients

Testimonial

What our clients say about JJCC Group

Clients trust JJCC Group for expert FDA cGMP guidance, ensuring compliant, high-quality drug and biologics manufacturing.

JJCC streamlined our cGMP compliance process, making FDA audits easier and improving overall manufacturing quality.

Scientist in lab coat holding pipette
Sarah Bennett OWNER

Absolutely! Their expertise in regulatory guidance and training has been invaluable for our drug and biologics operations.

Smiling female doctor with stethoscope
Bts Ashik OWNER

Their team provides consistent, professional support, ensuring our facility maintains full compliance and operational excellence.

Smiling male doctor in white coat, arms crossed
Shadin De Manager
wpChatIcon